FDA Budget Offers Update On Domestic Incentives For Para IV Filings

Also Covers Drug-Device Combinations And Interchangeability

 
• By Dave Wallace
  
The FDA is proposing incentivizing domestic production with early Paragraph IV filings (Shutterstock)

More from FDA

More from Regulatory Landscape